Back
Takeda Pharmaceutical Vs. Nxera Pharma Industry Stock Comparison
Sell
20
TKPHF
Takeda Pharmaceutical
Last Price:
25.26
Seasonality Move:
5.67%
Sell
49
SOLTF
Nxera Pharma
Last Price:
8.05
Seasonality Move:
18.65%
Sell
20
Takeda Pharmaceutical (TKPHF)
is a Sell
Is Takeda Pharmaceutical a Buy, Sell or Hold?
- The current Takeda Pharmaceutical [TKPHF] share price is $25.26. The Score for TKPHF is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
- TKPHF is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
49
Nxera Pharma (SOLTF)
is a Sell
Is Nxera Pharma a Buy, Sell or Hold?
- The current Nxera Pharma [SOLTF] share price is $8.05. The Score for SOLTF is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
- SOLTF is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
TKPHF Stock Price Chart
What is Takeda Pharmaceutical's stock price today?
-
The Takeda Pharmaceutical share price today is $25.26
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and TKPHF is experiencing buying pressure, which is a positive indicator for future bullish movement.
SOLTF Stock Price Chart
What is Nxera Pharma's stock price today?
-
The Nxera Pharma share price today is $8.05
The current trend is relatively stagnant and SOLTF is experiencing slight buying pressure.
TKPHF Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.56 | Sell |
| Relative Strength Index (14 RSI): | 30.3 | Sell |
| Chaikin Money Flow: | 345 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (25.89 - 27.53) | Sell |
| Bollinger Bands (100): | (26.21 - 28.37) | Sell |
SOLTF Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.01 | Sell |
| Relative Strength Index (14 RSI): | 52.73 | Buy |
| Chaikin Money Flow: | 0 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (7.37 - 8.05) | Buy |
| Bollinger Bands (100): | (7.99 - 10.09) | Sell |
TKPHF Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 25.8 | Sell |
| 20-day SMA: | 26.59 | Sell |
| 50-day SMA: | 27.33 | Sell |
| 200-day SMA: | 27.22 | Sell |
| 8-day EMA: | 25.81 | Sell |
| 20-day EMA: | 26.42 | Sell |
| 50-day EMA: | 27.01 | Sell |
| 200-day EMA: | 27.5 | Sell |
SOLTF Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 8.05 | Sell |
| 20-day SMA: | 7.75 | Buy |
| 50-day SMA: | 8.28 | Sell |
| 200-day SMA: | 9.4 | Sell |
| 8-day EMA: | 8.02 | Buy |
| 20-day EMA: | 7.95 | Buy |
| 50-day EMA: | 8.25 | Sell |
| 200-day EMA: | 9.38 | Sell |
Takeda Pharmaceutical Earnings Growth & TKPHF Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Nxera Pharma Earnings Growth & SOLTF Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Takeda Pharmaceutical Technical Analysis
| Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Nxera Pharma Technical Analysis
| Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||